Fresenius Medical Care Corporation
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more
Fresenius Medical Care Corporation (FMS) - Net Assets
Latest net assets as of December 2025: $14.28 Billion USD
Based on the latest financial reports, Fresenius Medical Care Corporation (FMS) has net assets worth $14.28 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($31.00 Billion) and total liabilities ($16.72 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $14.28 Billion |
| % of Total Assets | 46.07% |
| Annual Growth Rate | 7.5% |
| 5-Year Change | 2.17% |
| 10-Year Change | 29.24% |
| Growth Volatility | 11.56 |
Fresenius Medical Care Corporation - Net Assets Trend (1998–2025)
This chart illustrates how Fresenius Medical Care Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Fresenius Medical Care Corporation (1998–2025)
The table below shows the annual net assets of Fresenius Medical Care Corporation from 1998 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $14.28 Billion | -9.42% |
| 2024-12-31 | $15.77 Billion | +6.35% |
| 2023-12-31 | $14.83 Billion | -4.03% |
| 2022-12-31 | $15.45 Billion | +10.52% |
| 2021-12-31 | $13.98 Billion | +13.36% |
| 2020-12-31 | $12.33 Billion | -6.78% |
| 2019-12-31 | $13.23 Billion | +2.52% |
| 2018-12-31 | $12.90 Billion | +19.15% |
| 2017-12-31 | $10.83 Billion | -2.02% |
| 2016-12-31 | $11.05 Billion | +15.11% |
| 2015-12-31 | $9.60 Billion | +16.41% |
| 2014-12-31 | $8.25 Billion | +20.06% |
| 2013-12-31 | $6.87 Billion | -1.34% |
| 2012-12-31 | $6.96 Billion | +11.94% |
| 2011-12-31 | $6.22 Billion | +9.94% |
| 2010-12-31 | $5.66 Billion | +19.22% |
| 2009-12-31 | $4.75 Billion | +7.88% |
| 2008-12-31 | $4.40 Billion | +15.02% |
| 2007-12-31 | $3.82 Billion | +2.05% |
| 2006-12-31 | $3.75 Billion | +11.28% |
| 2005-12-31 | $3.37 Billion | +24.96% |
| 2004-12-31 | $2.69 Billion | +4.17% |
| 2003-12-31 | $2.59 Billion | -4.07% |
| 2002-12-31 | $2.70 Billion | -9.01% |
| 2001-12-31 | $2.96 Billion | +3.09% |
| 2000-12-31 | $2.87 Billion | +42.92% |
| 1999-12-31 | $2.01 Billion | -0.75% |
| 1998-12-31 | $2.03 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Fresenius Medical Care Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 17774.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $12.21 Billion | 85.47% |
| Common Stock | $14.28 Billion | 100.00% |
| Total Equity | $14.28 Billion | 100.00% |
Fresenius Medical Care Corporation Competitors by Market Cap
The table below lists competitors of Fresenius Medical Care Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VÃ¥r Energi AS
PINK:VARRY
|
$4.49 Billion |
|
Hargreaves Lansdown plc
PINK:HRGLF
|
$4.49 Billion |
|
WHITE MTNS INS. GRP DL 1
F:WNI
|
$4.49 Billion |
|
Banco Bpm SpA
LSE:0RLA
|
$4.49 Billion |
|
Kiwoom
KO:039490
|
$4.49 Billion |
|
Axos Financial Inc
NYSE:AX
|
$4.49 Billion |
|
Belden Inc
NYSE:BDC
|
$4.48 Billion |
|
Macy’s Inc
NYSE:M
|
$4.48 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fresenius Medical Care Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 14,576,563,000 to 14,283,000,000, a change of -293,563,000 (-2.0%).
- Net income of 978,000,000 contributed positively to equity growth.
- Dividend payments of 405,839,470 reduced retained earnings.
- Share repurchases of 562,185,376 reduced equity.
- Other comprehensive income increased equity by 328,545,000.
- Other factors decreased equity by 632,083,154.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $978.00 Million | +6.85% |
| Dividends Paid | $405.84 Million | -2.84% |
| Share Repurchases | $562.19 Million | -3.94% |
| Other Comprehensive Income | $328.55 Million | +2.3% |
| Other Changes | $-632.08 Million | -4.43% |
| Total Change | $- | -2.01% |
Book Value vs Market Value Analysis
This analysis compares Fresenius Medical Care Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.94x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.84x to 0.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $4.79 | $23.16 | x |
| 1999-12-31 | $4.20 | $23.16 | x |
| 2000-12-31 | $5.29 | $23.16 | x |
| 2001-12-31 | $7.00 | $23.16 | x |
| 2002-12-31 | $6.37 | $23.16 | x |
| 2003-12-31 | $6.13 | $23.16 | x |
| 2004-12-31 | $4.16 | $23.16 | x |
| 2005-12-31 | $5.70 | $23.16 | x |
| 2006-12-31 | $6.23 | $23.16 | x |
| 2007-12-31 | $6.44 | $23.16 | x |
| 2008-12-31 | $7.19 | $23.16 | x |
| 2009-12-31 | $7.81 | $23.16 | x |
| 2010-12-31 | $9.18 | $23.16 | x |
| 2011-12-31 | $9.99 | $23.16 | x |
| 2012-12-31 | $11.02 | $23.16 | x |
| 2013-12-31 | $10.98 | $23.16 | x |
| 2014-12-31 | $12.82 | $23.16 | x |
| 2015-12-31 | $15.73 | $23.16 | x |
| 2016-12-31 | $16.29 | $23.16 | x |
| 2017-12-31 | $15.98 | $23.16 | x |
| 2018-12-31 | $19.14 | $23.16 | x |
| 2019-12-31 | $13.48 | $23.16 | x |
| 2020-12-31 | $41.90 | $23.16 | x |
| 2021-12-31 | $10.84 | $23.16 | x |
| 2022-12-31 | $11.93 | $23.16 | x |
| 2023-12-31 | $23.21 | $23.16 | x |
| 2024-12-31 | $24.84 | $23.16 | x |
| 2025-12-31 | $24.53 | $23.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fresenius Medical Care Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.85%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.98%
- • Asset Turnover: 0.63x
- • Equity Multiplier: 2.17x
- Recent ROE (6.85%) is below the historical average (9.06%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 0.81% | 0.54% | 0.62x | 2.41x | $-184.69 Million |
| 1999 | -12.41% | -6.47% | 0.67x | 2.87x | $-445.99 Million |
| 2000 | 7.92% | 5.05% | 0.70x | 2.23x | $-59.41 Million |
| 2001 | 2.42% | 1.30% | 0.75x | 2.49x | $-222.89 Million |
| 2002 | 10.32% | 5.70% | 0.75x | 2.42x | $8.65 Million |
| 2003 | 10.21% | 5.99% | 0.74x | 2.31x | $5.41 Million |
| 2004 | 11.06% | 6.45% | 0.78x | 2.19x | $28.41 Million |
| 2005 | 11.45% | 6.72% | 0.85x | 2.01x | $48.62 Million |
| 2006 | 11.02% | 6.32% | 0.65x | 2.68x | $37.68 Million |
| 2007 | 12.86% | 7.38% | 0.69x | 2.54x | $109.47 Million |
| 2008 | 13.71% | 7.70% | 0.71x | 2.50x | $159.03 Million |
| 2009 | 13.35% | 7.92% | 0.71x | 2.37x | $156.07 Million |
| 2010 | 13.26% | 8.12% | 0.71x | 2.32x | $181.05 Million |
| 2011 | 13.56% | 8.37% | 0.66x | 2.47x | $216.80 Million |
| 2012 | 13.27% | 8.60% | 0.62x | 2.50x | $221.22 Million |
| 2013 | 12.02% | 7.60% | 0.63x | 2.50x | $135.01 Million |
| 2014 | 11.07% | 6.60% | 0.62x | 2.69x | $82.79 Million |
| 2015 | 9.80% | 6.15% | 0.66x | 2.43x | $-18.84 Million |
| 2016 | 11.85% | 6.94% | 0.67x | 2.56x | $184.13 Million |
| 2017 | 13.03% | 7.20% | 0.74x | 2.45x | $297.99 Million |
| 2018 | 16.86% | 11.98% | 0.63x | 2.23x | $806.16 Million |
| 2019 | 10.03% | 6.86% | 0.53x | 2.75x | $3.83 Million |
| 2020 | 9.44% | 6.52% | 0.56x | 2.57x | $-68.72 Million |
| 2021 | 7.63% | 5.50% | 0.51x | 2.71x | $-300.57 Million |
| 2022 | 4.81% | 3.47% | 0.54x | 2.56x | $-725.54 Million |
| 2023 | 3.66% | 2.57% | 0.57x | 2.49x | $-863.03 Million |
| 2024 | 3.69% | 2.78% | 0.58x | 2.30x | $-919.74 Million |
| 2025 | 6.85% | 4.98% | 0.63x | 2.17x | $-450.30 Million |
Industry Comparison
This section compares Fresenius Medical Care Corporation's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fresenius Medical Care Corporation (FMS) | $14.28 Billion | 0.81% | 1.17x | $4.49 Billion |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |